NeoGenomics, Inc.NEONASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank28
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P28
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-84.88%
Q3 2025-56.30%
Q2 2025180.27%
Q1 2025-358.44%
Q4 20245.99%
Q3 2024-33.44%
Q2 2024153.61%
Q1 2024-245.72%
Q4 2023423.52%
Q3 2023-255.10%
Q2 202387.80%
Q1 2023-244.42%
Q4 202277.35%
Q3 20224.26%
Q2 202241.47%
Q1 2022-46.84%
Q4 2021-154.62%
Q3 2021-458.78%
Q2 2021-162.90%
Q1 2021-63.07%
Q4 20201037.83%
Q3 2020-72.05%
Q2 2020127.15%
Q1 2020-306.40%
Q4 2019-81.97%
Q3 2019494.70%
Q2 2019-177.43%
Q1 2019-60.54%
Q4 201884.38%
Q3 201826.22%
Q2 2018-53.61%
Q1 2018148.52%
Q4 2017-22.55%
Q3 201713.91%
Q2 2017487.19%
Q1 2017-599.59%
Q4 2016-102.50%
Q3 201682.29%
Q2 2016-22.55%
Q1 2016221.36%